<div class="container">

<table style="width: 100%;"><tr>
<td>known.designs</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Show the 'known' designs</h2>

<h3>Description</h3>

<p>Returns the known study designs for which power and sample size can be calculated within this package.
</p>


<h3>Usage</h3>

<pre><code class="language-R">known.designs()
</code></pre>


<h3>Details</h3>

<p>This function is for informal purposes and used internally for obtaining characteristics of the designs used in calculation formulas.
</p>


<h3>Value</h3>

<p>Returns a data.frame with <br></p>
<table>
<tr style="vertical-align: top;">
<td><code>no</code></td>
<td>
<p>number of the design</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>design</code></td>
<td>
<p>character string for identifying the design</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>df</code></td>
<td>
<p>degrees of freedom of the design</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>df2</code></td>
<td>
<p>‘robust’ degrees of freedom of the design</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>steps</code></td>
<td>
<p>step width in the iterative sample size estimation</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>bk</code></td>
<td>
<p>so-called design constant in terms of total n</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>bkni</code></td>
<td>
<p>design constant in terms of number of subjects in (sequence) groups</p>
</td>
</tr>
</table>
<p>The design character string has to be used in the functions calls for power and sample size.
</p>


<h3>Note</h3>

<p>The design string for higher order crossover designs is named as:<br><code>treatments x sequences x periods</code> in case of replicate designs and<br><code>treatments x periods</code> in case of crossover designs for more then 2 treatments 
with number of sequences equal number of treatments.<br><br>
The df for the replicate crossover designs are those without carry-over in the model.<br>
Chen <em>et al.</em> used models with carry-over, <em>i.e.</em>, one df lower than here.<br><br>
The design constant bk in case of design 2x2x4 is here bk=1.<br>
Chen <em>et al.</em> used bk=1.1 due to carry-over in the model.<br><br>
n is the <b>total</b> number of subjects for all designs implemented.<br>
df2 = degrees of freedom for the so-called ‘robust’ analysis (aka Senn’s basic estimator).<br>
These degrees of freedom are often also more appropriate in case of evaluation via a ‘true’ 
mixed model (<em>e.g.</em> the FDA’ for replicate designs).<br><br>
The design <code>2x2x2r</code> is the 2-treatment-2-sequence-2-period design with 
2 repeated targets determined in each period (sequences TT|RR or RR|TT) described 
by Liu. Implemented are the characteristics of this design for the evaluation 
via assuming no S×F interaction and equal variabilities of Test and Reference.
</p>


<h3>Author(s)</h3>

<p>D. Labes
</p>


<h3>References</h3>

<p>Chen KW, Chow SC, Liu G. <em>A Note on Sample Size Determination for Bioequivalence Studies with 
Higher-order Crossover Designs.</em> J Pharmacokin Biopharm. 1997;25(6):753–65.
</p>
<p>Senn S. <em>Cross-over Trials in Clinical Research.</em> Chichester: John Wiley &amp; Sons; 2<sup>nd</sup> edition 2002.
</p>
<p>U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). <em>Guidance for Industry. Statistical Approaches to Establishing Bioequivalence.</em> January 2001. <a href="https://www.fda.gov/media/70958/download">download</a>
</p>
<p>Liu J-p. <em>Use of the Repeated Crossover design in Assessing Bioequivalence.</em> Stat Med. 1995;14(9-10):1067–78.
</p>


<h3>Examples</h3>

<pre><code class="language-R">known.designs()
</code></pre>


</div>